logo
搜索
菜单

diabetes的搜索结果

当前1/4页
排序: 今日浏览数
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice 10.3791/3188-v
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer 10.3791/4321-v
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Metabolic Profile Analysis of Zebrafish Embryos 10.3791/4300-v
Metabolic Profile Analysis of Zebrafish Embryos
Extraction of Tissue Antigens for Functional Assays 10.3791/4230-v 08:32 min
Extraction of Tissue Antigens for Functional Assays
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets 10.3791/4080-v 09:31 min
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT 10.3791/4060-v 10:53 min
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
Collection Protocol for Human Pancreas 10.3791/4039-v 07:49 min
Collection Protocol for Human Pancreas
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract 10.3791/4016-v 13:56 min
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
A System for ex vivo Culturing of Embryonic Pancreas 10.3791/3979-v 10:51 min
A System for ex vivo Culturing of Embryonic Pancreas
Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS) 10.3791/3875-v 14:15 min
Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS)
22.10: Peripheral Artery Disease I: Introduction 01:30 min
22.10: Peripheral Artery Disease I: Introduction
17.2: Coronary Artery Disease II: Pathophysiology 01:26 min
17.2: Coronary Artery Disease II: Pathophysiology
Improving IV Insulin Administration in a Community Hospital 10.3791/3705-v
Improving IV Insulin Administration in a Community Hospital
13.9: Assessment of the Cardiovascular System I: Subjective Data 01:23 min
13.9: Assessment of the Cardiovascular System I: Subjective Data
4.13: Restless Leg Syndrome and Night Terrors 01:27 min
4.13: Restless Leg Syndrome and Night Terrors
4.6: Insufficient Sleep and Sleep Deprivation 01:13 min
4.6: Insufficient Sleep and Sleep Deprivation
25.16: Hypoglycemia and Glucagon 01:15 min
25.16: Hypoglycemia and Glucagon
25.14: Glucagon-like Receptor Agonists 01:24 min
25.14: Glucagon-like Receptor Agonists
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors 01:19 min
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
25.11: Oral Hypoglycemic Agents: Biguanides and Glitazones 01:26 min
25.11: Oral Hypoglycemic Agents: Biguanides and Glitazones
返回顶部